Navigation Links
European Commission and EMBL renew cooperation
Date:3/4/2011

In a Memorandum of Understanding signed today, the European Commission (EC) and the European Molecular Biology Laboratory (EMBL) formalise their desire to maintain and further develop their cooperation.

"I am delighted to sign the renewed and strengthened Memorandum of Understanding between the European Commission and the European Molecular Biology Laboratory. I am confident that it will set the stage for even better and more fruitful cooperation between us. EMBL's excellent research is fundamental to our understanding of life itself and will underpin many of the advances we will see in medicine and other domains in the years to come," says Mire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science.

In signing this statement, Geoghegan-Quinn and Iain Mattaj, Director General of EMBL, renew their institutions' commitment to cooperate to further the development of European research in the life sciences.

"As the European intergovernmental institution for molecular life sciences, EMBL has extensive scientific and technical expertise coupled with years of success empowering life scientists from European countries to conduct cutting-edge research at state-of-the art research infrastructures," Mattaj says. With a contribution of 12.4 million Euro in 2010, the EC is EMBL's single largest external funding body.

The pledge of mutual consultation and collaboration signed today in Heidelberg, Germany, at EMBL's main laboratory, reinforces the aims of the 1995 Administrative Agreement between the EC and EMBL, and updates it in keeping with the evolution of the European Commission and the research landscape in Europe over the past 15 years. The two parties pledge to consolidate and further develop the European Research Area, notably in the areas of research programming, training and mobility of researchers, research infrastructures, management of intellectual property and international collaboration.


'/>"/>

Contact: Sonia Furtado
sonia.furtado@embl.de
European Molecular Biology Laboratory
Source:Eurekalert

Page: 1

Related biology news :

1. 8 special sessions at European Congress on Osteoporosis and Osteoarthritis in Valencia
2. IOF calls for action following release of Eastern European & Central Asian Regional Audit
3. European Multidisciplinary Conference in Thoracic Oncology -- press program
4. Finland initiates European biomedical research infrastructures construction with $6.7 million for 2011
5. SEBM European Best Poster Prize awarded at Annual Conference of the German Society for Gene Therapy
6. European R&D leaders assembled in Tel Aviv will invest $70 million in joint R&D initiatives
7. Israeli Minister of Industry and Trade to address European R&D leaders in Tel Aviv
8. Transgenic corn suppresses European corn borer, saves farmers billions
9. Cellectis to Present at the Annual Congress of the European Society of Gene & Cell Therapy
10. Watch your seas: Marine scientists call for European marine observatory network
11. The European IVF Monitoring Group celebrates its 10-year anniversary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... 2, 2017 Summary This report provides ... its partnering interests and activities since 2010. ... Read the full report: ... since 2010 report provides an in-depth insight into the partnering ... On demand company reports are prepared upon purchase ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , a ... globally, announces significant enhancements to new and core technologies ... New products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity ... technology provides the fastest and most accurate capture software ...
(Date:2/24/2017)... Spain , Feb. 24, 2017  EyeLock LLC, a ... demonstrate its elite iris biometric solution on the ... X16 LTE at Mobile World Congress 2017 ... Qualcomm,s Booth in Hall 3, Stand 3E10. ... the Qualcomm Haven™ security platform—a combination of ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), ... the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is ... ) and the US National Institutes of Health. ... ... ...
(Date:3/27/2017)... The new research portal will give visitors quick and ... Valero Energy , offering extensive market research on their performance ... ... The latest trend gaining momentum in the ... though touted as a green alternative to fossil fuels, is ...
(Date:3/27/2017)... 2017  Trovagene, Inc. (NASDAQ: TROV), a precision medicine ... Bill Welch , will be presenting at this ... AM EDT at the Essex House in ... Scientific Officer, Mark Erlander , Ph.D., will also ... The presentation will be webcast live at ...
(Date:3/24/2017)... 24, 2017 MiMedx Group, Inc. (NASDAQ: MDXG), ... placental tissue allografts and patent-protected processes to develop and ... healthcare, announced today  that it will present at the ... , NY.  Parker H. "Pete" Petit, Chairman and CEO, ... Christopher M. Cashman , EVP and Chief Commercialization Officer, ...
Breaking Biology Technology: